4//SEC Filing
Smith Mark Alan 4
Accession 0001415889-22-002297
CIK 0001411685other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:16 PM ET
Size
5.7 KB
Accession
0001415889-22-002297
Insider Transaction Report
Form 4
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+150,000→ 150,000 totalExercise: $1.37Exp: 2032-03-01→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan. Twenty-five percent (25%) of the total number of shares vest immediately on March 1, 2022 (the "Vesting Start Date") and 1/24th of the remaining number of shares shall vest monthly thereafter until all awarded shares are fully vested two (2) years after the Vesting Start Date.
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001677452
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:16 PM ET
- Size
- 5.7 KB